Wuhan Easy Diagnosis Biomedicine Co.,Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Wuhan Mingde Biotechnology Co., Ltd. (002932. SZ) was established in 2008 and is located in the national biological industry base - Wuhan Optics Valley Biological City. It is a national high-tech enterprise that focuses on the independent research and development, production, and sales of in vitro diagnostic products, providing comprehensive solutions for medical informatization based on five major centers and third-party medical laboratory services. After years of technological accumulation, we have built a rich product matrix supported by 10 major technology platforms, covering immune, blood gas, and molecular diagnosis product lines. We have formed a regional collaborative and intelligent diagnosis overall solution based on real-time and accurate diagnosis products, and bridged by emergency and critical illness information systems, achieving a full process layout of pre hospital, in hospital, and post hospital. At present, our business covers 7500 medical institutions in 30 provinces, municipalities, and autonomous regions across the country, providing product services and technical support to over 50 countries and regions worldwide. Mingde Biological focuses on the treatment of critical and critical diseases, in compliance with the new requirements of national emergency and emergency services, and provides medical institutions with a comprehensive solution of "emergency and critical care information management platform+inspection and inspection equipment+center certification consultation+normalized operation", achieving the full process management of "prevention, rescue, treatment, and health", and assisting in the intelligent transformation and upgrading of the five major centers in the country, as well as the construction of a specialized disease prevention and control system. After years of deep cultivation and adhering to the customer-centric service philosophy, Mingde has not only gained recognition from customers, but also gained high recognition from the industry. In 2020 and 2021, Mingde won the Outstanding Contribution Award for Informatization Construction of China Chest Pain Center for two consecutive years, and successfully ranked among the top 50 medical informatization enterprises in China in 2023. Mingde Biotechnology attaches great importance to technology accumulation and product research and development innovation. It has an independent research and development center and a high-tech research and development team. As of now, Mingde Biotechnology has obtained more than 200 Class II and III medical device registration certificates, and owns more than 100 independent intellectual property rights, including core invention patents, software works, etc. More than 100 products have passed EU CE certification and NMPA certification. After years of deep cultivation, Mingde Biological has developed into a leading supplier of in vitro diagnostic comprehensive solutions in China. It has successively won the "National Small Giant Enterprise Award", "National Enterprise Technology Center", "National Science and Technology System to Combat the COVID-19- Advanced Collective", "Top 100 Chinese Pharmaceutical Influential Enterprises", "Golden Bull Award of the Most Investment Value" and other honors, and has been awarded the "Best Listed Company in Hubei" for many consecutive years. Mingde Biology will continue to provide high-quality products and services for human health, create a service loop centered on human medical and health needs, and always fulfill the mission of allowing everyone to enjoy health. |
| Headquarter | Wuhan |
| Establish Date | 1/28/2008 |
| Listed Code | 002932.SZ |
| Listed Date | 7/10/2018 |
| Chairman | Chen Lili. |
| CEO | Chen Lili. |
| Website | www.mdeasydiagnosis.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
